[Federal Register Volume 71, Number 148 (Wednesday, August 2, 2006)]
[Notices]
[Page 43719]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-6638]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License of a U.S. Government-Owned 
Patent

AGENCY: Department of the Army, DoD

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), 
announcement is made of the intent to grant an exclusive, royalty-
bearing, revocable license to U.S. provisional patent number 60/723,442 
filed October 5, 2005 entitled ``Small Molecule Inhibitors of Botulinum 
Neurotoxins,'' to Microbiotix, Inc. with its principal place of 
business at 1 Innovation Drive, STE 15, Worcester, Massachusetts 01605-
4332.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to the grant of 
this license can file written objections along with supporting 
evidence, if any, 15 days from the date of this publication. Written 
objections are to be filed with the Command Judge Advocate, U.S. Army 
Medical Research and Materiel Command, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 06-6638 Filed 8-1-06; 8:45 am]
BILLING CODE 3710-08-M